Molecular Therapy: Methods & Clinical Development

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Molecular Therapy: Methods & Clinical Development is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,900 USD. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2329-0501
Country
United States
Languages
english
Access
Open access
Declared publication charge
3,900 USD
Articles in DOAJ
1678
Declared review time
24 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2015-03-18
  • PUBMED · 2014-01-08
Indexing
DOAJ · PUBMED
APC
3,900 USD
Declared review time (DOAJ)
24 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2025
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1678

Most recent article

11 months ago

Average review time (journal-declared via DOAJ)

24weeks

Works in OpenAlex

1845

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

92

i10-index

1161

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2015-03-18
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
86%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Molecular therapy. Methods and clinical developmentMethods & clinical development
Source type
journal
NLM unique ID (PubMed)
101624857
Classification4

Subjects (DOAJ)

Science: Biology (General): GeneticsScience: Biology (General): Cytology

LCC codes

QH426-470QH573-671

Subject areas

  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
Show all subjects (50)
  • Viral Infectious Diseases and Gene Expression in Insects
  • Viral Infectious Diseases and Gene Expression in Insects
  • Viral Infections and Immunology Research
  • Viral Infections and Immunology Research
  • Retinal Development and Disorders
  • Retinal Development and Disorders
  • Lysosomal Storage Disorders Research
  • Lysosomal Storage Disorders Research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Muscle Physiology and Disorders
  • Muscle Physiology and Disorders
  • Viral gastroenteritis research and epidemiology
  • Viral gastroenteritis research and epidemiology
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • RNA regulation and disease
  • RNA regulation and disease
  • Herpesvirus Infections and Treatments
  • Herpesvirus Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Cytomegalovirus and herpesvirus research
  • Neurogenetic and Muscular Disorders Research
  • Neurogenetic and Muscular Disorders Research
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • HIV Research and Treatment
  • Retinal Diseases and Treatments
  • Retinal Diseases and Treatments
  • HIV Research and Treatment
  • Nerve injury and regeneration
  • Animal Virus Infections Studies
  • Animal Virus Infections Studies
  • Nerve injury and regeneration
  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research

Keywords (DOAJ)

  • technology development
  • molecular therapy
  • gene therapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: